Chick-limb mesodermal cells have been maintained in tissue culture under conditions that permit development of muscle and cartilage. 3-Acetylpyridine, a nicotinamide-antagonized muscle teratogen, potentiates chondrogenic expression in cell cultures, as evidenced by histological and biochemical criteria, including the production of chondromucoprotein. Xylosyltransferase and N-acetylgalactosaminyltransferase are two enzymes required for chondromucoprotein synthesis; the specific activities of these enzymes were measured in differentiating mesodermal cells cultured for various periods of time in the presence and absence of 3-acetylpyridine and in intact limb tissue. The ratios of specific enzyme activities were nearly the same in both cultured cells and limb tissue, although the levels of both transferases increased severalfold during chondrogenic expression by mesodermal cells in culture. 3-Acetylpyridine causes the specific activities of xylosyl-and N-acetylgalactosaminyltransferases to increase 10-and 2-fold, respectively, above those of untreated cultures. Compared to the ratio of transferase activities in limb tissue and differentiating cell cultures, 3-acetylpyridine appears to increase the activity of xylosyltransferase, the initiator of chondroitin sulfate chain synthesis, more than does N-acetylgalactosaminyltransferase; this finding implies that the synthesis of these two enzymes may be separately regulated.
Mesenchymal tissue of embryonic chick limb differentiates into cartilage and soft tissues, including muscle, during limb development. Irreversible expression of the chondrogenic phenotype by prospective cartilage cells seems to occur by stage 25 (1) (2) (3) . By this time, cells at the core of the embryonic limb exhibit morphological and biochemical characteristics of chondrocytes, including a high rate of chondromucoprotein synthesis (4) and a marked accumulation of extracellular material (5) .
Mesodermal cells can be obtained readily from chick-limb buds before stage 25 and maintained in tissue culture (6) (7) (8) .
Under permissive conditions, these cells undergo phenotypic changes characteristic of differentiating chondrogenic and myogenic cells (6, 7, 9) . Tissue culture techniques have provided an opportunity to observe how various factors influence phenotypic expression (8) , including the effects of teratogenic compounds that interfere with the expression of normal chondrogenic or myogenic characteristics (6, 7, 9, 10) . The activity of one such group of teratogens is completely neutralized by the coadministration of nicotinamide, and it has been postulated that variations in the concentration of nicotinamide or pyridine nucleotides within the embryonic tissue may be an important factor in the determination of phenotypic expression of mesenchymal cells.
One nicotinamide-antagonized teratogen, 3-acetylpyridine, causes severe muscular hypoplasia in ovo (11) (12) (13) . The inhibition of muscle development in ovo has been corroborated by tissue culture studies in which 3-acetylpyridine treatment of embryonic chick mesodermal cells inhibited myoblast formation almost completely (6, 7, 9) . Concomitant with inhibition of myogenesis was an apparent potentiation of chondrogenic activity, i.e., greater numbers of cells appeared to be engaged in cartilage synthesis in treated cultures than in untreated ones (6, 7, 9) . This observation has been supported, in part, by the finding that the specific activity of UDP-glucose pyrophosphorylase, an enzyme involved in the formation of precursors of the acid mucopolysaceharides and other complex carbohydrates, was dramatically higher in 3-acetylpyridine-treated cultures than in controls (9) . This study further investigates the effect of 3-acetylpyridine on the activities of two enzymes involved in chondromucoprotein synthesis, xylosyltransferase and N-acetylgalactosaminyl- (14.7 Ci/mol) was synthesized as described (14) . Smith-degraded proteoglyean from bovine cartilage was a gift from A. L. Horwitz. Chondroitin-4-sulfate hexasaccharide was prepared by partial enzymic degradation of bovine chondroitin-4-sulfate (15) . All (17) .
Chondroitin sulfate N-acetylgalactosaminyltransferase activity was measured after dialysis against 50 mM HEPES buffer (pH 7.0)-50 mM KC1. Enzyme activity was assayed by the transfer of N-[3H]acetylgalactosamine from the uridinenucleotide sugar to the nonreducing uronic acid residue of a chondroitin-4-sulfate hexasaccharide (18) with the assay described by Horwitz and Dorfman (14) .
Analytical Methods. DNA was assayed by the method of Burton (19) , after hot (800) 5% trichloroacetic acid extraction of precipitates obtained by treatment of sonicates with 9%
cold trichloroacetic acid. Protein was measured by the procedure of Lowry et al. (20) , after exhaustive dialysis of the samples against 50 mM NaCI to remove interfering substances. Radioactivity was measured (17) in a liquid scintillation spectrometer. All assays were performed a minimum of three times.
RESULTS
The specific activities of xylosyltransferase and N-acetylgalactosaminyltransferase were measured in mesodermal cells obtained from the limbs of chick embryos (stage [23] [24] 
Glycosyltransferases
The specific activity of xylosyltransferase in control cultures increased more than 10-fold during the first five days (Fig. 2) . Between days 5 and 9 the specific activity fell about 40%, during which time the cell number increased by a similar percentage (see Fig. 1 ). These results suggest that phenotypic commitment, including the synthesis of cell-specific enzymes, occurs primarily during the first five or six days of culture, after which time the differentiated phenotypes persist. The observed decline in the activity of xylosyltransferase in culture between days 5 and 9 may not be real with respect to the actual population of chondrocytes. Fibroblasts proliferated rapidly during this period and contributed proportionately more toward the total DNA and protein than toward the glycosyltransferase activity, thus causing the specific activity of xylosyltransferase in cultures to decrease.
The presence of 3-acetylpyridine caused no marked change in the specific activity profile of xylosyltransferase during the first five days of culture (Fig. 2) , but a striking change occurred over the next four days. The specific activity of xylosyltransferase in treated cultures continued to increase-as opposed to that in control cultures-until, by day 9, the specific activity of the transferase was seven times greater than in untreated cultures of the same age. On a per-cell basis, these differences in the specific activity of xylosyltransferase suggested that treated cultures contained 10-to 13-times more chondrocytes (7) than control cultures. This finding agrees with the previously reported observation that 7-to 20-times (Table 1) .
Enzyme activities were measured in intact limb, so the differences that undoubtedly arise between chondrogenic and myogenic areas were not distinguished. The specific activities of xylosyltransferase and N-acetylgalactosaminyltransferase averaged 1700 and 3500 cpm per hr per mg of protein for limb tissue of all stages (Table 1) , values comparable to those found in cultured cells on day 3, and remained remarkably constant throughout development, as did the ratio of enzyme activities. The total enzyme activity did increase during development, but did so largely in proportion to the increasing mass of limb tissue. These results may be indicative of the amounts of enzyme that exist in vivo under conditions where the levels of days in culture.
of the two enzymes may be coordinately controlled.
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Treatment of mesodermal cells of embryonic chick limb with the nicotinamide-antagonized muscle teratogen, 3-acetylpyridine, prevents the normal differentiation of prospective myogenic cells. Its action interferes with the expression of myogenic activity and increases the proportion of chondrogenic cells in culture, as evidenced by histological staining procedures and increased activity of biosynthetic enzymes involved in the synthesis of acid mucopolysaccharides (6, 7, 9, (11) (12) (13) . It is important to point out that increased specific activities of biosynthetic enzymes in cell cultures does not imply increased concentrations of enzymes on a per-cell basis but, rather, is a consequence of the fact that treated cultures contain a greater proportion of chrondrogenic cells. Studies reported here on xylosyltransferase and those reported earlier (9) provide support for this conclusion.
It should be stressed that cotreatment with nicotinamide completely reverses the effects of 3-acetylpyridine and, in addition, seems to block chondrogenic expression (6, 7). 3-Acetylpyridine inhibits the incorporation of nicotinamide by cells and reduces the amounts of pyridine nucleotides synthesized (9) . Thus, the effect of 3-acetylpyridine may result in part from a reduction in the intracellular pyridine-nucleotide pools, which in turn decreases the reductive capacity of cells and compels a greater reliance on glycolytic metabolism. Under the metabolic stress produced by 3-acetylpyridine, certain subpopulations, such as prospective myoblasts, are eliminated (6, 7). Thus, while treatment with 3-acetylpyridine may cause a reduction in the number of cells per culture compared to untreated controls, a high proportion of the surviving cells may ultimately express chondrogenic activity.
A second explanation for the fact that there are fewer cells in treated cultures is that 3-acetylpyridine may have a selective toxicity for cells whose presence inhibits expression by progenitor chondrocytes. If such inhibitory cells were removed by 3-acetylpyridine, then treated cultures would also exhibit increased potentiation of chondrogenic expression. This view is consistent with the observation that mixing of heterotypic cells and cartilage cells causes a striking inhibition of sulfate uptake (22) . A third possibility is that 3-acetylpyridine is toxic to all cells in culture at the concentrations used, and that prospective chondrocytes respond to this condition by increasing their production of glycosyltransferase involved in synthesis of chonidromucoprotein. Three observations argue against the last explanation: (i) Although 3-acetylpyridine does affect some cell types adversely (6, 23) , it seems to selectively enhance chondrogenic expression in a substantial portion of limb mesodermal cells (6, 7, 9) . (ii) Different cell types within the limb mesoderm exhibit different survival characteristics after trypsinization. The myogenic phenotype seems to be particularly sensitive to trypsin (21) , and a high proportion of these cells may be damaged irreversibly and fail to thrive. (iii) Although chick mesodermal cells have been exposed to large numbers of compounds known to produce toxic effects in vivo, none of these compounds has potentiated chondrogenic activity like 3-acetylpyridine.* Additionally, it can be shown that turnover of mucopolysaccharides labeled with Na235SO4, [3H]glucosamine, or ['4C ]galactosamine in cell cultures occurs at about the same rates in the presence or absence of 3- acetylpyridine,* eliminating the possibility that glycosaminoglycan metabolism ceases in treated cells.
The mechanisms by which a population of embryonic mesodermal cells, exhibiting no apparent differentiated characteristics, receive signals to undergo differentiation either in tissue culture or in vivo are unknown. It seems unreasonable that before or during differentiation cells synthesize the enzymes and precursors required for the formation of specialized cell products. Furthermore, it might be anticipated that synthesis of enzymes that act in concert to catalyze the synthesis of complex molecules would be coordinately regulated. Thus, the activity profiles of xylosyltransferase and N-acetylgalactosaminyltransferase in untreated mesodermal cells or normal limb tissue may be regarded as the normal ratio of enzyme activities present before and during cartilage differentiation. This point of regulation is strikingly apparent when enzyme levels in untreated cultures of limb mesodermal cells and intact limbs are compared. Both samples have levels of enzyme that are proportional to one another (compare control values in Figs. 2 and 3 to those in Table 1 ), and both have about the same maximal specific activities (2000-3000 cpm per hr per mg of protein and 4000-5000 cpm per hr per mg of protein for the xylosyl-and N-acetylgalactosaminyltransferases, respectively).
Treatment with 3-acetylpyridine increased the activity of both transferases in vitro, but increased the specific activity of xylosyltransferase 5-to 10-fold and N-acetylgalactosaminyltransferase only 2-fold, in comparison with the specific activity of enzymes in untreated cultures after 9 days. It is possible that 3-acetylpyridine disrupts the developmental program and affects increased synthesis of xylosyltransferase, the chondroitin sulfate chain initiator, but that enzymes involved in subsequent steps in the pathway (such as Nacetylgalactosaminyltransferase) are not sensitive to the influence of 3-acetylpyridine. Another situation in which the level of xylosyltransferase activity seems greater than that which would be expected based on the levels of associated enzyme activities exists in a rat chondrosarcoma (24) .t It is of interest that 3-acetylpyridine treatment greatly enchances the activity of UDPG-pyrophosphorylase (9); however, the rate of chondromucoprotein synthesis is not coordinately enhanced. It would seem that chondromucoprotein synthesis is dependent on several complex factors, including the synthesis and intracellular location of both structural (core protein) and catalytic (glycosyltransferases) proteins. For example, one factor not investigated here has been reported by Nevo and Dorfman, who observed that 35SO4-2 incorporation into glycosaminoglycans in cultured chondrocytes was stimulated in the presence of chondromucoprotein, but that this increased sulfate uptake was not accompanied by any demonstrable change in xylosyltransferase activity (25) . Although 3-acetylpyridine influences the metabolic state of cells in culture while enhancing chondrogenic expression, it is difficult to precisely evaluate the relationship between the reduced reductive capacity of treated cells and the synthesis of chondromucoprotein.
